Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation

B.W.M. Willemse, D.S. Postma, W. Timens, N.H.T. ten Hacken
European Respiratory Journal 2004 23: 464-476; DOI: 10.1183/09031936.04.00012704
B.W.M. Willemse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D.S. Postma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. Timens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N.H.T. ten Hacken
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Smoking is the main risk factor in the development of chronic obstructive pulmonary disease (COPD), and smoking cessation is the only effective treatment for avoiding or reducing the progression of this disease.

Despite the fact that smoking cessation is a very important health issue, information about the underlying mechanisms of the effects of smoking cessation on the lungs is surprisingly scarce. It is likely that the reversibility of smoke-induced changes differs between smokers without chronic symptoms, smokers with nonobstructive chronic bronchitis and smokers with COPD. This review describes how these three groups differ regarding the effects of smoking cessation on respiratory symptoms, lung function (forced expiratory volume in one second), airway hyperresponsiveness, and pathological and inflammatory changes in the lung.

Smoking cessation clearly improves respiratory symptoms and bronchial hyperresponsiveness, and prevents excessive decline in lung function in all three groups.

Data from well-designed studies are lacking regarding the effects on inflammation and remodelling, and the few available studies show contradictory results. In chronic obstructive pulmonary disease, a few histopathological studies suggest that airway inflammation persists in exsmokers. Nevertheless, many studies have shown that smoking cessation improves the accelerated decline in forced expiratory volume in one second, which strongly indicates that important inflammatory and/or remodelling processes are positively affected.

  • chronic obstructive pulmonary disease
  • inflammation
  • review
  • smoking cessation

Footnotes

    • © ERS Journals Ltd
    View Full Text
    PreviousNext
    Back to top
    View this article with LENS
    Vol 23 Issue 3 Table of Contents
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Alerts
    Sign In to Email Alerts with your Email Address
    Citation Tools
    The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
    B.W.M. Willemse, D.S. Postma, W. Timens, N.H.T. ten Hacken
    European Respiratory Journal Mar 2004, 23 (3) 464-476; DOI: 10.1183/09031936.04.00012704

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation
    B.W.M. Willemse, D.S. Postma, W. Timens, N.H.T. ten Hacken
    European Respiratory Journal Mar 2004, 23 (3) 464-476; DOI: 10.1183/09031936.04.00012704
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Abstract
      • Definitions, selection of articles and structure
      • Collection of data
      • Respiratory symptoms
      • Lung function (forced expiratory volume in one second)
      • Airway hyperresponsiveness
      • Pathological and inflammatory changes in the lungs
      • Discussion
      • Conclusion
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Humanl LPS models in systemic and pulmonary inflammation
    • Diagnosis of CTEPH after acute pulmonary embolism
    • Clinical considerations in individuals with AAT PI*SZ genotype
    Show more Reviews

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • CME
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Submit a manuscript
    • ERS author centre

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2021 by the European Respiratory Society